Private equity-driven merger and acquisition activity in cardiology peaked in 2023, followed by a decline in 2024, according to a corporate finance report released in October 2024 by KPMG.
Continued demand for cardiovascular services alongside advancements in healthcare technology has made cardiology a target of private equity investment in the last five years.
Here’s a year-by-year breakdown of PE-driven cardiology transactions as of October 2024:
• 2024: 12
• 2023: 28
• 2022: 12
• 2021: 4
• 2020: 7
• 2019: 10
